ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OHI vs NLY // EV/EBITDA & P/E VALUATION

Omega Healthcare Investors Inc. (NYSE) VS. Annaly Capital Management Inc. (NYSE) • 15-METRIC TALLY: OHI 4 — NLY 7
▲ EV/EBITDA & P/E VALUATION LEADER: NLY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OHI VS. NLY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OHI NLY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 0.00% 4.00% -4.00 NLY /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 95.0x 18.2x +76.80 NLY /valuation <GO>
Free Cash Flow Yield 5.81% 3.50% +2.31 OHI /fcf-yield <GO>
Operating Margin 0.10% 61.40% -61.30 NLY /operating-margins <GO>
Net Profit Margin 0.10% 50.40% -50.30 NLY /net-margins <GO>
Revenue Growth (YoY) 13.20% 4.40% +8.80 OHI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.50% 11.50% -6.00 NLY /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 9/9 7/9 +2.00 OHI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.7 39.4 +17.30 OHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.08 1.15 -0.07 NLY /macro-sensitivity <GO>
Forward P/E Multiple — 6.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $14.24B $14.36B -$127.2M NLY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OHI REV NLY REV OHI GROSS % NLY GROSS % OHI FCF NLY FCF
FY 2025 $1.19B $0 — — $825.0M $692.9M
FY 2024 $1.05B $0 — — $702.1M $3.31B
FY 2023 $949.7M $0 — — $575.0M $2.37B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OHI // BETA 1.08
NLY // BETA 1.15